🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Google's Verily in early stages of developing a coronavirus tool

Published 03/13/2020, 05:58 PM
Updated 03/13/2020, 06:01 PM
Google's Verily in early stages of developing a coronavirus tool
GOOGL
-
GOOG
-

WASHINGTON (Reuters) - Google said a life sciences division, Verily, is in the early stages of developing a tool to help triage Americans who may need testing for the coronavirus.

"Verily is in the early stages of development, and (is) planning to roll testing out in the Bay Area, with the hope of expanding more broadly over time," Google's communications department announced in a statement on Twitter.

Shares of Google parent Alphabet (NASDAQ:GOOGL) Inc closed up more than 9% after U.S. President Donald Trump said on Friday that the search giant would create a website to help determine whether individuals need a coronavirus test or not. The president said that 1,700 company engineers were working on the site.

Like Google, Verily is a subsidiary of Alphabet, which is based in Mountain View, California.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.